Elligo Health Research acquires ePatientFinder’s Clinical Trial Exchange platform and its network of referring medical practices. The move expands Elligo’s capabilities in connecting patients with clinical trials and streamlining trial enrollment processes.
Elligo Health Research acquires ePatientFinder’s Clinical Trial Exchange platform and referring practice network to improve clinical trial matching. The company targets the 97% of physicians not currently offering clinical research to patients. Elligo aims to expand its trial engagement capabilities through the acquisition.
Circuit Clinical and ePatientFinder are collaborating to form the largest U.S. clinical research site network. The partnership combines their existing networks, serving over 200 clinical sites nationwide. ePatientFinder specializes in electronic health record (EHR) patient identification, while Circuit Clinical operates a practice-based clinical research network.
ePatientFinder and Allscripts introduce **GeoPrecise**, a heatmap tool leveraging EHR data to optimize clinical trial site selection and patient identification. The solution maps patient demographics and trial eligibility criteria to pinpoint high-potential locations for recruitment. By integrating electronic health records (EHRs), GeoPrecise aims to streamline the identification of qualified participants for clinical trials.
ePatientFinder secures $8.2 million in funding to expand its Clinical Trial Exchange platform, a cloud-based solution for clinical trial matching and coordination. The Austin, Texas-based company focuses on streamlining patient recruitment and trial management for healthcare providers and researchers. The investment supports further development of its technology infrastructure and operational capabilities.
Austin-based **ePatientFinder** secures **$8.2 million in Series B funding** from a healthcare technology investor syndicate. The company operates in the healthtech sector, leveraging its platform to streamline patient data access and coordination. This round follows prior investment to expand its operational capabilities and market reach.